Felbinac

Especificaciones

5728-52-9Número CAS

227-233-2Número CE

2-(4-phenylphenyl)acetic acidNombre IUPAC

C14H12O2Fórmula química

212.24 g/molPeso molecular

felbinac; 4-BIPHENYLACETIC ACID; 5728-52-9; Traxam; Dolinac; Napageln; biphenyl-4-ylacetic acid; 4-Carboxymethylbiphenyl; p-Biphenylylacetic acid; Felbinaco; Felbinacum; LJC 10,141; L-141; LJC-10141; Flexfree; DTXSID0045389; Ly-61017; NSC-16284; 94WNJ5U8L7; CL-83544; CHEBI:31597; CL 83,544; DTXCID8025389; [1,1'-Biphenyl]-4-ylacetic acid; (1,1'-biphenyl)-4-ylacetic acid; RefChem:140075; M02AA08; 227-233-2; 4-Biphenylylacetic acid; 2-(4-phenylphenyl)acetic acid; Seltouch; [1,1'-Biphenyl]-4-acetic acid; p-Biphenylacetic acid; Biphenyl-4-acetic acid; 4-Biphenylaceticacid; 2-([1,1'-biphenyl]-4-yl)acetic acid; Acetic acid, (4-biphenylyl)-; CL 83544; LY 61017; (1,1'-Biphenyl)-4-acetic acid; MFCD00004351; NSC 16284; 4-phenylphenylacetic acid; MLS000069466; 2-(biphenyl-4-yl)acetic acid; NCGC00016660-01; 2-{[1,1'-biphenyl]-4-yl}acetic acid; SMR000059071; CAS-5728-52-9; Felbinacum [Latin]; Felbinaco [Spanish]; Selspot; Sumilu; Felbinac; (Biphenyl-4-yl)acetic acid; Biphenyl-4-yl-acetic acid; (Biphenyl-4-yl)acetic acid; Felbinac [USAN:INN:BAN:JAN]; EINECS 227-233-2; BRN 1211592; UNII-94WNJ5U8L7; Dolonac; Ledergel; Napagel; L 141; Felbinac CRS; Zenol EXUM; BP4; Dolinac (TN); Felbinac (Standard); Felbinac Impurity 2; BPAA; EMEC; 4-biphenyl acetic acid; 4-biphenyl-acetic acid; FELBINAC [USAN]; Opera_ID_534; FELBINAC [INN]; FELBINAC [JAN]; FELBINAC [MI]; 4-biphenylyl acetic acid; Prestwick0_000893; Prestwick1_000893; Prestwick2_000893; Prestwick3_000893; (4'-biphenyl)acetic acid; Epitope ID:613405; FELBINAC [WHO-DD]; Oprea1_058748; SCHEMBL26084; BSPBio_000706; 4-Biphenylacetic acid, 98%; 4-Biphenylacetic acid(methoxymethyl)-1,1'-biphenyl; SPBio_002915; 4-[l,l'biphenyl]ylacetic acid; BPBio1_000778; CHEMBL413965; Felbinac (JP18/USAN/INN); orb1224625; orb1310198; SCHEMBL1510273; SCHEMBL5746957; FELBINAC [EP MONOGRAPH]; 1,1'-biphenyl-4-ylacetic acid; HY-B0641R; HFN-310; BDBM223312; HMS1570D08; HMS2097D08; HMS3714D08; HMS5081P18; Pharmakon1600-01506160; CS-D1194; HY-B0641; NSC16284; Tox21_110549; AR1730; EBC-04197; NSC760372; s3685; SBB056750; STK387569; AKOS000119696; Tox21_110549_1; ([1,1'-Biphenyl]-4-yl)acetic acid; [1,1'-Biphenyl]-4-ylacetic acid #; AC-8104; AS-2883; CCG-213621; CS-8026; DB07477; FF23234; NSC-760372; NCGC00016660-02; NCGC00016660-03; NCGC00016660-04; NCGC00016660-06; DB-022648; AB00384278; B1278; NS00008983; ST50308310; T0888; EN300-20102; D01675; AB00384278_14; F018235; SR-01000003008; 4-Biphenylacetic acid(Discontinued,See C4X-25282); Q3742067; SR-01000003008-2; BRD-K91740057-001-16-4; BRD-K91740057-001-19-8; F2191-0076; Felbinac, European Pharmacopoeia (EP) Reference Standard; Z104476858Sinónimos